LPL Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,219
Closed -$820K 5725
2025
Q1
$820K Sell
6,219
-22,039
-78% -$2.75M ﹤0.01% 3728
2024
Q4
$2.36M Buy
28,258
+7,878
+39% +$647K ﹤0.01% 2712
2024
Q3
$1.49M Buy
20,380
+9,820
+93% +$738K ﹤0.01% 3010
2024
Q2
$723K Buy
10,560
+1,366
+15% +$94.7K ﹤0.01% 3547
2024
Q1
$636K Buy
9,194
+266
+3% +$18.3K ﹤0.01% 3581
2023
Q4
$639K Sell
8,928
-462
-5% -$26.6K ﹤0.01% 3455
2023
Q3
$489K Buy
9,390
+1,387
+17% +$80.8K ﹤0.01% 3505
2023
Q2
$507K Buy
8,003
+90
+1% +$5.61K ﹤0.01% 3440
2023
Q1
$428K Sell
7,913
-683
-8% -$33K ﹤0.01% 3456
2022
Q4
$455K Sell
8,596
-645
-7% -$32.3K ﹤0.01% 3334
2022
Q3
$430K Buy
9,241
+249
+3% +$13K ﹤0.01% 3293
2022
Q2
$513K Sell
8,992
-2,450
-21% -$139K ﹤0.01% 3175
2022
Q1
$700K Sell
11,442
-2,799
-20% -$145K ﹤0.01% 2913
2021
Q4
$745K Sell
14,241
-676
-5% -$28.4K ﹤0.01% 2916
2021
Q3
$556K Buy
14,917
+391
+3% +$13.6K ﹤0.01% 3121
2021
Q2
$593K Buy
14,526
+837
+6% +$30.9K ﹤0.01% 3006
2021
Q1
$464K Sell
13,689
-911
-6% -$31.6K ﹤0.01% 3085
2020
Q4
$464K Buy
14,600
+105
+0.7% +$2.76K ﹤0.01% 2832
2020
Q3
$372K Buy
14,495
+1,397
+11% +$31.9K ﹤0.01% 2733
2020
Q2
$336K Buy
13,098
+1,015
+8% +$20.5K ﹤0.01% 2751
2020
Q1
$186K Sell
12,083
-4,872
-29% -$106K ﹤0.01% 2839
2019
Q4
$582K Sell
16,955
-1,018
-6% -$12.2K ﹤0.01% 2241
2019
Q3
$134K Buy
+17,973
New +$172K ﹤0.01% 3113

Other funds holding ITCI